A peelable, lightweight film, developed by UT Austin professor Maria Croyle, can preserve live viruses, bacteria and antibodies without refrigeration. Credit: The University of Texas at Austin.
Access to vaccines around the world could get easier thanks to scientists in the College of Pharmacy at The University of Texas at Austin who have developed an inexpensive and innovative vaccine delivery method that preserves live viruses, bacteria, antibodies and enzymes without refrigeration.
Maria A. Croyle and her research team in the lab of the Division of Molecular Pharmaceutics and Drug Delivery at UT Austin have released a research paper describing a peelable lightweight film that stabilizes biologics and withstands extreme temperature changes. The technology has already demonstrated proof of concept for model Ebola and H1N1 vaccines, and it may prove to be an effective method of delivery for future treatments of pathogens such as the coronavirus that causes COVID-19.
“It is essentially a plug and play platform,” said Croyle, who is the Glaxo Wellcome Endowed Professor of Pharmaceutics at UT. “Once we know the specific qualities of a vaccine candidate, we can adapt the film’s components to meet those requirements, suspending and sealing it within the film matrix in a way that allows it to withstand extreme temperature changes and release the vaccine components in a precise and controlled manner.”
The research team published its findings in the journal Science Advances.
As researchers develop vaccines and biologic treatments for deadly diseases, a second challenge comes in distributing those treatments to remote, developing and low-income areas around the world. More than half of the leading causes of death in low-income countries were the result of infectious disease, while costs associated with storage and shipping vaccines and biological drugs make up 40% of the cost of drugs in the Western world.
Croyle’s film is not only inexpensive, but nearly one-thousandth the size of traditional vaccine vials and requires no refrigeration throughout the delivery and administration process. The technology could significantly increase the survival rates for existing preventable diseases and drastically reduce the timetable and cost to combat emerging diseases before they spread worldwide.
The film technology developed by Croyle has been licensed to a new startup company based in Chapel Hill, North Carolina. Early investors include the founders of Asklepios BioPharmaceutical Inc. (AskBio). The company was established to develop the film technology for applications in stabilizing biological therapeutics, such as vaccines, anti-infective and chemotherapeutic agents, and gene therapy products.
“We are excited to partner with AskBio to develop Maria’s platform technology,” said Erin Overstreet, director of licensing in UT Austin’s Office of Technology Commercialization. “We believe the technology is poised to help patients with rare diseases, with the potential to help many other patients as well, and look forward to seeing the technology benefit the public.”
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
Vaccine delivery method
- How the leading coronavirus vaccines workon October 6, 2020 at 8:57 pm
There are now quite a few COVID-19 vaccines in the pipeline , but two seem to be making promising progress: the one designed by the US biotechnology company Moderna , and the one developed by the ...
- Coronavirus live news: Chinese vaccines to be assessed; Japan-South Korea travel plan revealedon October 6, 2020 at 3:34 am
WHO to look at China’s vaccines; Japan and South Korea to resume business travel ...
- Rich countries are total vaccine hogs. Covid-19 must change thaton October 4, 2020 at 10:14 pm
When swine flu hit, poor countries missed out on vaccines. Public health experts are trying to stop that happening again with Covid-19 ...
- Hoping to receive 50 crore doses of COVID-19 vaccine by July: Harsh Vardhanon October 4, 2020 at 2:54 pm
The minister also said that the government is keeping an eye on immunity data with regard to Covid-19 disease while finalizing these plans, as reported by this newspaper earlier.
- Govt targeting 400-500 million doses of Covid-19 vaccine by July ’21on October 4, 2020 at 11:31 am
The National Democratic Alliance (NDA) government plans to receive and utilise 400-500 million doses of the coronavirus disease (Covid-19) vaccine, when one is ready, to induce protection against the ...
Go deeper with Google Headlines on:
Vaccine delivery method
Go deeper with Bing News on:
Vaccine delivery without refrigeration
- Vaxxas Announces $22 Million Award from U.S. Government to Advance Vaxxas Needle-Free HD-MAP™ Vaccine Patch Technology for Pandemic Responseon October 5, 2020 at 5:05 am
Vaxxas Announces $22 Million Award from U.S. Government to Advance Vaxxas Needle-Free HD-MAP™ Vaccine Patch Technology for Pandemic Response ...
- New Thin Film Technology to Revolutionize Storage and Distribution of Biologic Treatments and Vaccineson September 29, 2020 at 6:00 am
Jurata Thin Film, a company focused on revolutionizing how biologics are shipped and stored, is bringing to market a new technology that allows ...
- COVID-19 vaccine distribution will put FedEx’s 'cold chain' to the teston September 27, 2020 at 7:11 pm
As FedEx and other couriers gear up for the “peak season” of the holidays, another peak is looming: the mass distribution of a COVID-19 vaccine.
- VXRT Stock: Vaxart Shoots Higher on Human Trial Approvalon September 14, 2020 at 3:31 pm
without refrigeration. Although Vaxart now must race to catch up with some of its rivals, it is clear investors have not given up on VXRT stock. Perhaps its unique method of vaccine delivery will ...
- Vaxart Announces FDA Clearance of IND Application for Oral COVID-19 Vaccine and Provides Update on COVID-19 Programon September 14, 2020 at 9:04 am
Vaxart vaccines are administered using convenient room temperature-stable tablets that can be stored and shipped without refrigeration ... tablet vaccine delivery platform is suitable to deliver ...